Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
28 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hyundai-bioscience-to-conduct-phase-3-clinical-trial-for-high-risk-group-of-covid-19-patients-with-the-goal-of-emergency-use-authorization-302232773.html
11 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adm-korea-announces-niclosamide-based-metabolic-anticancer-drugs-first-clinical-trial-target-as-prostate-cancer-patients-resistant-to-hormone-therapy-302194534.html
25 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hyundai-bioscience-succeeds-in-developing-multi-treatment-for-mosquito-borne-viral-infections-including-dengue-fever-302182515.html
22 Apr 2024
// BIOSPECTRUM ASIA
https://www.biospectrumasia.com/news/25/24109/korean-firm-hyundai-bioscience-soon-to-initiate-global-clinical-development-on-dengue-antiviral-candidate.html
https://www.prnewswire.com/news-releases/hyundai-bioscience-announces-that-xafty-is-the-only-antiviral-that-can-be-immediately-used-for-the-treatment-of-dengue-fever-301955962.html
02 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hyundai-bioscience-announced-positive-phase-2-clinical-study-results-of-the-global-blockbuster-candidate-for-the-covid-19-antiviral-drug-301814076.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?